Evaluation of Chemoradiotherapy of Low Dose Carboplatin (CBDCA) for Head and Neck Cancer.

Practica Otologica- Japan

doi 10.5631/jibirin.88.751

Full Text

Abstract

Available in

Categories

Otorhinolaryngology

Date

January 1, 1995

Authors

Yusuke WATANABE

Publisher

The Society of Practical Otolaryngology

Related search

Combined MTX-5FU-CBDCA for the Treatment of Head and Neck Cancer.

Practica Otologica

Otorhinolaryngology

English

Importance of AUC of Carboplatin in Head and Neck Cancer.

Journal of Otolaryngology of Japan

Otorhinolaryngology

English

Evaluation of Weekly Paclitaxel, Carboplatin, and Cetuximab in Head and Neck Cancer Patients With Incurable Disease

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

A Comparative Evaluation of Accelerated Radiotherapy Versus Concomitant Chemoradiotherapy in Management of Locally Advanced Head and Neck Cancer

European Journal of Medicine

English

The Impact of Active Nutritional Support for Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy

Siriraj Medical Journal

English

A Pilot Study of Carboplatin (JM8, CBDCA) and Chlorambucil in Combination for Advanced Ovarian Cancer

British Journal of Cancer

Cancer Research

English

Sequential Chemoradiotherapy for Advanced Head and Neck Cancer: A Clinical Study With 33 Cases

Journal of Otolaryngology of Japan

Otorhinolaryngology

English

Risk Factors for Aspiration Pneumonia During Concurrent Chemoradiotherapy or Bio-Radiotherapy for Head and Neck Cancer

Cancer Research

English

Dose-Volume Factors Correlating With Trismus Following Chemoradiation for Head and Neck Cancer

Acta Oncologica

Nuclear Medicine

English